Venetoclax or Ruxolitinib Depletion of Recipient NK Cells,...

Biology of Blood and Marrow Transplantation 2020 / 03 Vol. 26; Iss. 3

Venetoclax or Ruxolitinib Depletion of Recipient NK Cells, in Combination with Reduced Intensity Conditioning, Improves Donor Cell Engraftment without Gvhd in a Mouse Model of Allosct.

Ritchie, David Stuart, Du, Kelei, Koldej, Rachel, Huntington, Nicholas, Davis, Joanne
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.033
Date:
March, 2020
File:
PDF, 184 KB
2020
Conversion to is in progress
Conversion to is failed